Surgical Sealants And Adhesives Industry Overview
The global surgical sealants and adhesives market size was valued at USD 1.82 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 11.4% from 2022 to 2030. Sealants and adhesives have evolved to become useful accompaniments in modern surgical procedures. They are widely preferred because of their safety, efficacy, and usability in repairing injured tissues and supporting wounds obtained during surgery. The pandemic caused by COVID-19 across the globe resulted in nationwide lockdowns and exerted pressure on the healthcare settings. According to the list provided by the American College of Surgeons, all dental, medical, or surgical procedures that are nonessential and elective in nature were postponed, except for medical emergencies. Gather more insights about the market drivers, restrains and growth of the Global Surgical Sealants And Adhesives Market Factors contributing to the growth of this market are the rising demand for surgical services and increasing concerns to reduce surgical wounds. Globally, the number of surgeries being undertaken has increased significantly. According to the WHO estimations, approximately, 235 million major surgical procedures are undertaken worldwide every year. Surgical procedures are normally accompanied by the risk of wound infection, excessive bleeding, or tissue damage. In addition, patients suffering from diabetes need to be extra cautious as the chances of complications during and post-surgery are significantly higher in their case. As the volume of surgeries is increasing, extensive R&D activities focused on the widening applications of surgical sealants and adhesives are also rising. Traditional alternatives to surgical sealants are sutures and staples, which are expected to be replaced by surgical sealants and adhesives owing to their better wound closure capabilities with minimal blood loss. The sealants facilitate less painful operations and do not need removal. Currently, sealants are facing limited market growth owing to their high costs. In addition, strict regulatory approvals are creating substantial challenges in market growth. Browse through Grand View Research's Medical Devices Industry Research Reports.
Surgical Sealants And Adhesives Market Segmentation Grand View Research has segmented the global surgical sealants and adhesives market report on the basis of type, application, and region: Surgical Sealants And Adhesives Type Outlook (Revenue, USD Million, 2018 - 2030)
Surgical Sealants And Adhesives Application Outlook (Revenue, USD Million, 2018 - 2030)
Surgical Sealants And Adhesives Regional Outlook (Revenue, USD Million, 2018 - 2030)
Market Share Insights
Key Companies profiled: Some prominent players in the global surgical sealants and adhesives market include:
Order a free sample PDF of the Surgical Sealants And Adhesives Market Intelligence Study, published by Grand View Research. About Grand View Research Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
0 Comments
Pharmaceutical Analytical Testing Outsourcing Industry Overview
The global pharmaceutical analytical testing outsourcing market size was valued at USD 6.54 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 8.3% over the forecast period. Innovation in the pharmaceutical industry, increasing focus on regulation, safety & quality, rising number of end-users, and pricing benefits of outsourcing are the key factors driving the market. Increasing R&D budgets and investments in drug discovery are among the critical sustainability strategies for pharmaceutical companies. Not all companies have an infrastructure that is conducive to all types of analytical testing. Hence, outsourcing these operations is the most suitable option, which also helps save time and cost. Gather more insights about the market drivers, restrains and growth of the Global Pharmaceutical Analytical Testing Outsourcing Market Other factors, such as the increasing need for product safety & quality, along with changing regulations for in vivo and in vitro tests are also expected to propel the growth of the market. For instance, the government of China issued a notification to upgrade the quality of generic drugs, remove the backlog of drug applications, improve the quality and transparency of the review and approval process, and encourage new drug R&D in line with global development. The economic benefits associated with outsourcing these services and approvals in the pharmaceutical industry are projected to support market growth. Quicker and reliable results, data safety, and improved efficiency are some key factors favoring market growth. Innovation or new product development is directly proportional to the demand for testing services. Due to competitive pressures, pricing concerns, and lead-time to market, companies are opting to outsource testing services. According to the Pharma Intelligence Report 2019, the total development pipeline increased to 16,181 molecules in 2019 from 15,267 molecules in 2018. Increasing focus on customized care and technological advancements are shortening the product lifecycle, which has resulted in the rapid development of new products. The development of combination products, biosimilars, and other innovative medicines has led to an increase in demand for specific types of tests. Outsourcing services are becoming the most preferable option for many pharma companies to increase operational efficiency, therapeutic expertise, and on-demand services along with the expansion of geographical presence. Browse through Grand View Research's Pharmaceuticals Industry Research Reports.
Pharmaceutical Analytical Testing Outsourcing Market Segmentation Grand View Research has segmented the global pharmaceutical analytical testing outsourcing market report on the basis of service and region: Pharmaceutical Analytical Testing Outsourcing Service Outlook (Revenue, USD Million, 2016 - 2028)
Pharmaceutical Analytical Testing Outsourcing Regional Outlook (Revenue, USD Million, 2016 - 2028)
Market Share Insights
Key Companies profiled: Some prominent players in the global pharmaceutical analytical testing outsourcing market include:
Order a free sample PDF of the Pharmaceutical Analytical Testing Outsourcing Market Intelligence Study, published by Grand View Research. Regulatory Affairs Industry Overview The global regulatory affairs market size was valued at USD 11.8 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.4% from 2021 to 2028. This growth can be attributed to the increasing demand for the faster approval process, changing regulatory landscape, growth in emerging fields such as specialty therapies, orphan drugs, personalized medicines, and companion diagnostics. The market for regulatory affairs is also driven by the emergence of new diseases triggering the need for effective vaccines and therapies. Gather more insights about the market drivers, restrains and growth of the Global Regulatory Affairs Market The growing pace of innovation in digital health and the rapid technological advancements in data collection, analysis, and management is anticipated to create a need for digital transformation in one or more regulatory processes in order to improve the access and analysis of the continuously growing volume of information due to connected health products and programs. Furthermore, even several pharma/biotech companies are anticipated to upgrade their existing technologies to meet the growing healthcare needs. For instance, according to the 2018 Steve Gens Report, nearly 58% of survey pharma companies planned to enhance their Regulatory Intelligence (RI) capability while another study mentioned that 20 out of 22 participating companies considered leveraging AI for RI data processing activities. Presently, the healthcare industry is focused not only on the development of blockbuster therapies for the treatment of various diseases but also on targeted gene therapies, specialty drugs, and precision medicine that help treat specific diseases and disorders. Furthermore, some of these products are also being combined with medical devices to enhance the quality of drug delivery, dose, and patient monitoring or adherence, thus increasing the complexity of defining the regulatory strategy and pathway to market. Furthermore, launched or soon to be launched therapies, such as AbbVie’s JAK1 inhibitor, Alexion’s Ultomiris, Novartis/Avexis’ Zolgensma, Boehringer Ingelheim/AbbVie’s Skyrizi, Aimmune’s Palforzia, and bluebird bio’s Zynteglo, are expected to be blockbusters products by 2023, indicating huge opportunities in areas of intellectual property rights, commercialization strategies, and post-marketing strategies. Browse through Grand View Research's Medical Devices Industry Research Reports.
Regulatory Affairs Market Segmentation Grand View Research has segmented the global regulatory affairs market report on the basis of service, service provider, categories, product stage, company size, end use, indication, and region: Regulatory Affairs Service Outlook (Revenue, USD Million, 2016 - 2028)
Regulatory Affairs Categories Outlook (Revenue, USD Million, 2016 - 2028)
Regulatory Affairs Indication Outlook (Revenue, USD Million, 2016 - 2028)
Regulatory Affairs Product Stage Outlook (Revenue, USD Million, 2016 - 2028)
Regulatory Affairs Service Provider Outlook (Revenue, USD Million, 2016 - 2028)
Regulatory Affairs Company Size Outlook (Revenue, USD Million, 2016 - 2028)
Regulatory Affairs Regional Outlook (Revenue, USD Million, 2016 - 2028)
Market Share Insights
Key Companies profiled: Some of the prominent players in the regulatory affairs market include:
Order a free sample PDF of the Regulatory Affairs Market Intelligence Study, published by Grand View Research. About Grand View Research Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc. Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: [email protected] Web: https://www.grandviewresearch.com Follow Us: LinkedIn | Twitter Surgical Robots Industry Overview
The global surgical robots market size was valued at USD 3.6 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 19.3% from 2022 to 2030. The shortage of physicians and surgeons all over the globe and the increasing adoption of automated instruments used for surgery are the major factors driving the market. The increasing investments by the regional and international players in the introduction of new and technologically advanced surgical robots are also positively impacting the market growth. Furthermore, the growing prevalence of bone degenerative diseases and the rising number of hip and knee replacement surgeries due to the increasing cases of arthritis and osteoporosis are the major factors anticipated to fuel the market growth. For instance, according to the Agency for Healthcare Research and Quality report, over 4,50,000 hip replacement surgeries are performed each year in the U.S. In addition, as per the Australian Institute of Health and Welfare (AIHW) statistics, the total knee replacement rate for osteoarthritis has been increased by about 38% from 2005-2006 to 2017-2018. Gather more insights about the market drivers, restrains and growth of the Global Surgical Robots Market In addition, increasing regulatory approvals for the robots used in surgery is one of the prominent factors aiding the market growth. For example, in 2019, Intuitive Surgical Inc’s Ion robotic surgical system received 510(k) FDA clearance. Moreover, the growing adoption of assisted surgeries like hysterectomies, the increasing number of robotic systems for surgical interventions, and constant investments and R&D activities with respect to automated robotic systems by the manufacturers are the key factors supporting the market growth. Furthermore, several industrial strategic initiatives by top international players are anticipated to accelerate the market growth over the years. For instance, in 2019, Ethicon, a subsidiary of Johnson & Johnson, acquired Auris Health, which is a developer of a robotic technology platform. This acquisition is aimed at supporting the expansion of Ethion’s digital surgery portfolio to combat lung cancer. In addition, Stryker corporation, in 2019, acquired OrthoSpace, Ltd., which has helped in increasing the company’s surgical equipment portfolio. Therefore, such industrial initiatives are expected to propel the adoption of robots and the growth of the market. The technological advancements in the field of automated medical instruments such as the combination of cameras, high-definition 3D imaging, computing technology, sensors, remote navigation technology systems, robotic controlled catheters, and other accessories utilized for medical surgeries are also increasing the adoption of automated instruments, which is further anticipated to drive the market over the forecast years. Browse through Grand View Research's Medical Devices Industry Research Reports.
Surgical Robots Market Segmentation Grand View Research, Inc. has segmented the global surgical robots market report on the basis of application and region: Surgical Robots Application Outlook (Revenue, USD Million, 2016 - 2030)
Surgical Robots Regional Outlook (Volume, Units; Revenue, USD Million, 2016 - 2030)
Market Share Insights
Key Companies profiled: Some prominent players in the global surgical robots market include:
Order a free sample PDF of the Surgical Robots Market Intelligence Study, published by Grand View Research. About Grand View Research Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. Endoscopes Industry Overview The global endoscopes market size was valued at USD 12.6 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 9.4% from 2022 to 2030. The rise in prevalence of chronic disorders and the growing awareness for early detection of diseases through minimally invasive surgical procedures are some of the major factors anticipated to drive the market growth over the forecast years. In addition, favorable reimbursement policies, and increasing FDA approvals for endoscopic devices are also expected to boost the growth of the market over the years. For instance, in 2021, the United States Food and Drug Administration has granted 510(k) clearance to EndoFresh’s disposable digestive endoscopy system, a device developed to reduce the chance of contamination in gastrointestinal procedures. Gather more insights about the market drivers, restrains and growth of the Global Endoscopes Market Furthermore, endoscopic procedures have been largely adopted to diagnose and treat functional gastrointestinal disorders. Functional gastrointestinal disorders can affect any part of the gastrointestinal tract, including the stomach, esophagus, and intestines. The growing prevalence of functional gastrointestinal disorders, such as Irritable Bowel Syndrome (IBS), functional constipation, or functional dyspepsia, is also expected to accelerate the adoption of endoscopy devices and boost the market growth over the forecast years. For instance, in 2021, a multinational study published in the Gastroenterology journal on 33 countries reported that, globally, over 40% of persons have functional gastrointestinal disorders. In addition, obesity is a growing serious health problem globally due to unhealthy lifestyles and diets. It is associated with several gastrointestinal disorders, such as esophageal adenocarcinoma, erosive esophagitis, gastroesophageal reflux disease, colorectal polyps, and cancer. As per the Organization for Economic Co-operation and Development (OECD) data, the obesity rate is expected to grow at a significant rate by 2030. Nearly 47%, 39%, and 35% of the population in the U.S., Mexico, and England respectively are expected to be obese by 2030. Bariatric surgery is the most effective treatment option resulting in significant weight loss. However, the emergence of minimally invasive endoscopic sleeve gastroplasty procedures significantly reduces stomach volume. Browse through Grand View Research's Medical Devices Industry Research Reports.
Endoscopes Market Segmentation Grand View Research, Inc. has segmented the global endoscopes market report on the basis of product, application, end use, and region: Endoscopes Product Outlook (Revenue, USD Million, 2014 - 2030)
Endoscopes Application Outlook (Revenue, USD Million, 2014 - 2030)
Endoscopes End-use Outlook (Revenue, USD Million, 2014 - 2030)
Endoscopes Regional Outlook (Revenue, USD Million, 2014 - 2030)
Market Share Insights
Key Companies profiled: Some prominent players in the global endoscopes market include:
Order a free sample PDF of the Endoscopes Market Intelligence Study, published by Grand View Research. Digital Therapeutics Market Is Expected To Grow At A Lucrative CAGR Of 26.1% From 2022 To 20305/14/2022 Digital Therapeutics Industry Overview
The global digital therapeutics market size was valued at USD 4.20 billion in 2021 and is estimated to grow at a compound annual growth rate (CAGR) of 26.1% from 2022 to 2030. Increasing smartphone penetration in developed & developing countries, the cost-effectiveness of digital health technology for providers & patients, and increasing demand for integrated healthcare systems & patient-centric care are expected to drive the market. According to Kepios, in April 2021, there were 4.27 billion internet users globally, which is over 60% of the global population. As this number increases, the awareness about smart health tracking is expected to improve. Furthermore, the COVID-19 pandemic, supportive regulatory initiatives & early signs of reimbursement, and increasing prevalence of chronic diseases are also anticipated to fuel the market growth. Gather more insights about the market drivers, restrains and growth of the Global Digital Therapeutics Market The COVID-19 pandemic significantly impacted the market. A major COVID-related driver is a rise in demand for convenient and accessible digital health solutions. The April 2020 guidelines released by the FDA stated that for the duration of the pandemic, it will allow the distribution and use of digital health therapeutic devices for mental health disorders. Providers can, thus, commercialize their solutions without complying with usual regulatory requirements, provided the devices do not create any undue public health emergency. Growing regulatory initiatives are anticipated to propel the standardization and R&D in the market over the forecast period. For instance, the Software Pre-Cert Pilot Program is part of the Digital Health Innovation Action Plan of the FDA, intended for a more efficient regulatory oversight of Software-based Medical Devices (SaMD) developed by manufacturers. The program is aimed at developing an efficient regulatory oversight for assessing organizations to establish trust that they can develop high-quality SaMD products. As per the CDC’s National Center for Chronic Disease Prevention and Health Promotion, 6 in 10 American adults suffer from a chronic disease, while 4 out of 10 adults have 2 or more chronic diseases. Cardiovascular diseases, cancer, diabetes, chronic kidney disease, chronic lung disease, and Alzheimer’s have been identified as the leading causes of death and disability in the country. Poor nutrition, use of tobacco, alcoholism, and lack of physical exercise further increase the risk of developing a chronic disease. Healthcare costs are impacted exponentially as most chronic diseases do not exist in isolation and a patient often suffers from co-morbidities. Smartphone ownership is even becoming essential with improving global interconnectivity, economically and socially. Smartphone penetration is an important factor related to the growth of the market. Browse through Grand View Research's Healthcare IT Industry Research Reports.
Digital Therapeutics Market Segmentation Grand View Research has segmented the global digital therapeutics market report on the basis of application, end user, and region:
Market Share Insights
Key Companies profiled: Some prominent players in the global digital therapeutics market include
Order a free sample PDF of the Digital Therapeutics Market Intelligence Study, published by Grand View Research. About Grand View Research Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. Biological Safety Testing Products & Services Industry Overview
The global biological safety testing products & services market size was valued at USD 2.77 billion in 2018 and is expected to grow at a CAGR of 12.3% over the forecast period. The market is primarily driven by the increasing production of new-generation biologics by major pharmaceutical and biotechnology companies. The high prevalence of target diseases globally has encouraged companies to increase the production of advanced biologics. The rising need for biologics has resulted in unprecedented growth in the number of biopharmaceutical companies. Increasing competition to develop therapeutically advanced drugs on a large scale has compelled manufacturers to improve aspects of manufacturing processes such as productivity and cost-efficiency. Companies are thus implementing good manufacturing practices involving thorough biological testing at various levels of the production cycle, thereby aiding the market growth. Gather more insights about the market drivers, restrains and growth of the Global Biological Safety Testing Products & Services Market The rising number of government initiatives to promote biological safety testing products and services is anticipated to drive overall growth over the forecast period. The high rate of microbial contamination and bioburden while manufacturing pharmaceuticals and biologics is expected to drive government and private organizations to improve underlying biological safety practices. Moreover, the presence of regulatory authorities to enforce significant safety standards is anticipated to boost the adoption of testing tools. Stringent guidelines and recommendations issued by these authorities increase the incorporation of these tools by quality assurance technicians, thus fueling the market growth. Biological safety testing services are used to ensure the safety of vaccines and biopharmaceuticals by confirming the absence of bacterial contaminants. Companies are offering services such as toxicology testing, bioburden testing, and analytical testing, which assess products on parameters such as accuracy, specificity, linearity, and range. Browse through Grand View Research's Biotechnology Industry Research Reports.
Biological Safety Testing Products & Services Market Segmentation Grand View Research has segmented biological safety testing products & services market on the basis of product, application, test type, and region:
Market Share Insights
Key Companies profiled: Some prominent players in the global biological safety testing products & services market include
Order a free sample PDF of the Biological Safety Testing Products & Services Market Intelligence Study, published by Grand View Research. About Grand View Research Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. Pharmaceutical Manufacturing Market Will Grow Positively As Of Increasing Investment Flow Till 20285/10/2022 Pharmaceutical Manufacturing Industry Overview
The global pharmaceutical manufacturing market size was valued at USD 405.52 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 11.34% from 2021 to 2028. The pharmaceutical landscape has undergone a massive transformation with the emergence of new technologies, cost-effective, and more efficient manufacturing approaches. In addition, increasing investment flow in this space has impacted the market growth positively. Manufacturing floor downtime and the production of product waste are reduced by the implementation of robotic technology and Artificial Intelligence (AI). In addition, single-use disposable solutions have gained momentum in this industry and have replaced conventional open transfer manufacturing techniques. Furthermore, the paradigm shift towards integrated, smart, and data-rich paperless operations has resulted in error-free and precise production. Such ongoing developments have propelled drug manufacturing. Gather more insights about the market drivers, restrains and growth of the Global Pharmaceutical Manufacturing Market Constant progress in the field of personalized medicines has opened up numerous possibilities to target different health maladies and allowed the development of patient-centric models. This progress results in a shift from large batches to smaller batches for the development of complex medicines and autologous patient-centric treatments. This has also encouraged the manufacturers to redesign their supply chain to better align with the patient-centric health care system. A rise in drug approvals by the regulatory bodies is expected to fuel the drug manufacturing procedures. For instance, the FDA approved 59 drugs in 2018, 49 drugs in 2019, and 15 drugs up to April 2020. Furthermore, a large number of ongoing clinical trials have created numerous growth opportunities for market growth. Mergers & acquisitions in the pharmaceutical industry have increased in the past few years. Most of the well-established companies are consolidating to enhance their market position in the highly competitive environment. Whereas small- to mid-sized pharma companies are being acquired for their innovative capabilities. Moreover, stringent regulations to curb pharmaceutical prices have resulted in a large number of mergers & acquisitions. Browse through Grand View Research's Pharmaceuticals Industry Research Reports.
Pharmaceutical Manufacturing Market Segmentation Grand View Research has segmented the global pharmaceutical manufacturing market on the basis of molecule type, drug development type, formulation, routes of administration, therapy area, prescription, age group, sales channel, and region:
Market Share Insights
Key Companies profiled: Some prominent players in the global pharmaceutical manufacturing market include
Order a free sample PDF of the Pharmaceutical Manufacturing Market Intelligence Study, published by Grand View Research. In-Vitro Toxicology Testing Market Is Expected To Expand At A CAGR Of 10.7% From 2021 To 20285/10/2022 In-vitro Toxicology Testing Industry Overview
The global in-vitro toxicology testing market size was estimated at USD 22.7 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 10.7% from 2021 to 2028. Significant advancements in toxicology science are one of the primary factors driving the market. Also, high costs associated with conventional animal tests and socio-ethical concerns associated with animal tests are anticipated to boost the growth of the market for in-vitro toxicology testing. As in-vitro toxicology studies can help in minimizing liabilities related to late-stage failure in the drug discovery process, a high number of research studies and drug development programs for COVID-19 are expected to accelerate the market for in-vitro toxicology testing. More than 590 drugs for COVID-19 are in the development program as of November 2020. Such a high number of drug development programs is anticipated to boost the demand for in vitro toxicology testing services. Gather more insights about the market drivers, restrains and growth of the Global In-vitro Toxicology Testing Market Significant advancements in in-vitro toxicology assays to evaluate drug product safety along with the assessment of the potential effect of pharmaceuticals on cells and tissues are anticipated to bolster revenue generation in the market. With an increase in the need for such assays, companies have broadened their portfolio to serve demand in the market for in-vitro toxicology testing. Availability of different methods in biotechnology and bioinformatics division to carry out in-silico simulation on animal models is also attributive for influencing industry growth through to 2028. Moreover, the development of toxicology databases for in-silico analysis of different compounds is anticipated to fuel demand for in-vitro techniques thereby leading to sector progress. Considerable government funding for research coupled with definite reimbursement policies to develop automated and technologically advanced equipment for laboratory analysis and ex-vivo studies is expected to enhance market stability. On the contrary, unavailability of immunity testing and immune stimulation in current in-vitro tests is expected to hamper the growth of this industry. Browse through Grand View Research's Biotechnology Industry Research Reports.
In-vitro Toxicology Testing Market Segmentation Grand View Research has segmented the global in-vitro toxicology testing market on the basis of end-use, technology, method, application, and region:
Market Share Insights
Key Companies profiled: Some prominent players in the global in-vitro toxicology testing market include
Order a free sample PDF of the In-vitro Toxicology Testing Market Intelligence Study, published by Grand View Research. Spatial Genomics & Transcriptomics Industry Overview
The global spatial genomics and transcriptomics market size was valued at USD 163.8 million in 2020 and is expected to expand at a CAGR of 11.1% from 2021 to 2028. Architecture analysis of genome content in histological specimens is considered a cornerstone in several biomedical research and diagnostics. This is effectively addressed by the advent of spatial omics as a technology-driven field that involves the determination of high-throughput omics data procured from tissue and cell specimens, along with data for the organizational structure of cell content, resulting in the revenue growth of the market. Technologies being introduced in this market are a result of convergence between conventional imaging technologies and novel high-throughput sequencing technologies with methods that help determine positional information of DNAs and RNAs. Although this field holds significant potential in disease management, spatially resolved omics need better implementation for the development of new methods to boost the market growth. Gather more insights about the market drivers, restrains and growth of the Global Spatial Genomics & Transcriptomics Market Moreover, key market players are focused on expanding their spatial transcriptomics and genomics footprints by entering into strategic partnerships and collaborations with other players. Moreover, the companies are undertaking strategies to expand their customer base across the globe. For instance, in February 2020, Dovetail Genomics announced the global availability of its Dovetail HiChIP and Micro-C Kits. Dovetail Micro-C kits provide a better resolution of chromatin contacts at a mononucleosome level, whereas HiChIP technology combines the Micro-C and ChIP-seq into one workflow, which allows assaying protein-directed alterations to chromatin architecture, enabling assessment of its impact on gene expression. The onset of COVID-19 has partially offset the revenue growth of operating market players. However, NanoString’s GeoMx Digital Spatial Profiling accelerates SARS-CoV-2 research as it is well established to operate using FFPE samples—specimens that are being provided by COVID-19 autopsies. Thus, the current global pandemic has created considerable opportunities for the market players operating in the space. Browse through Grand View Research's Biotechnology Industry Research Reports.
Spatial Genomics & Transcriptomics Market Segmentation Grand View Research has segmented the global spatial genomics and transcriptomics market on the basis of technology, product, end-use, and region:
Market Share Insights
Key Companies profiled: Some prominent players in the global spatial genomics & transcriptomics market include
Order a free sample PDF of the Spatial Genomics & Transcriptomics Market Intelligence Study, published by Grand View Research. |
Archives
December 2023
Categories |